稳健医疗
(300888)
| 流通市值：171.03亿 | | | 总市值：171.80亿 |
| 流通股本：5.80亿 | | | 总股本：5.83亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 5,486,211,258.52 | 2,679,328,547.73 | 10,949,489,967.01 | 7,897,083,664.25 |
| 营业总成本 | 4,860,235,265.17 | 2,345,297,815.47 | 9,733,808,334.16 | 6,964,816,025.47 |
| 其他经营收益 | | | | |
| 营业利润 | 665,018,309.78 | 352,632,755.87 | 1,067,678,099.51 | 964,790,797.18 |
| 利润总额 | 662,367,542.06 | 348,167,827.71 | 1,047,820,850.18 | 950,585,909.52 |
| 净利润 | 545,267,082.64 | 270,757,847.97 | 814,117,727.77 | 774,825,239.94 |
| 每股收益 | | | | |
| 其他综合收益 | -22,542,370.04 | -16,596,636.92 | -1,581,626.72 | 4,502,126.6 |
| 综合收益总额 | 522,724,712.6 | 254,161,211.05 | 812,536,101.05 | 779,327,366.54 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 9,686,434,040.78 | 8,733,828,473.04 | 8,466,271,919.82 | 8,487,925,600.23 |
| 非流动资产: | | | | |
| 非流动资产合计 | 9,285,471,561.23 | 9,743,272,084.41 | 9,938,586,107.4 | 10,056,394,565.29 |
| 资产总计 | 18,971,905,602.01 | 18,477,100,557.45 | 18,404,858,027.22 | 18,544,320,165.52 |
| 流动负债: | | | | |
| 流动负债合计 | 5,141,664,744.51 | 4,691,576,384.28 | 4,869,394,060.73 | 5,030,445,913.76 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,338,542,661.57 | 1,242,058,950.14 | 1,242,882,537.6 | 1,251,024,954.65 |
| 负债合计 | 6,480,207,406.08 | 5,933,635,334.42 | 6,112,276,598.33 | 6,281,470,868.41 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 11,682,259,501.02 | 11,749,104,227.92 | 11,516,711,030.45 | 11,490,178,850.19 |
| 股东权益合计 | 12,491,698,195.93 | 12,543,465,223.03 | 12,292,581,428.89 | 12,262,849,297.11 |
| 负债和股东权益合计 | 18,971,905,602.01 | 18,477,100,557.45 | 18,404,858,027.22 | 18,544,320,165.52 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 5,739,512,419.15 | 2,730,475,721.29 | 12,454,198,998.27 | 8,148,683,350.67 |
| 经营活动现金流出小计 | 5,426,079,528.09 | 2,862,634,270.17 | 10,788,522,103.34 | 7,441,952,885.06 |
| 经营活动产生的现金流量净额 | 313,432,891.06 | -132,158,548.88 | 1,665,676,894.93 | 706,730,465.61 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,011,424,074.78 | 840,914,376.1 | 3,729,326,814.37 | 1,820,216,523.08 |
| 投资活动现金流出小计 | 2,312,166,458.93 | 762,881,007.98 | 4,004,943,541.59 | 1,407,605,583.7 |
| 投资活动产生的现金流量净额 | -300,742,384.15 | 78,033,368.12 | -275,616,727.22 | 412,610,939.38 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,196,707,899.27 | 376,638,212.02 | 2,863,329,658.11 | 2,289,114,970.64 |
| 筹资活动现金流出小计 | 953,635,585.25 | 199,838,389.99 | 4,043,224,578.16 | 3,001,689,818.96 |
| 筹资活动产生的现金流量净额 | 243,072,314.02 | 176,799,822.03 | -1,179,894,920.05 | -712,574,848.32 |
| 汇率变动对现金及现金等价物的影响 | -45,634,701.57 | -29,143,823.95 | -6,540,524.43 | 51,171.05 |
| 现金及现金等价物净增加额 | 210,128,119.36 | 93,530,817.32 | 203,624,723.23 | 406,817,727.72 |
| 期末现金及现金等价物余额 | 1,770,850,227.94 | 1,654,252,925.9 | 1,560,722,108.58 | 1,763,915,113.07 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 210,128,119.36 | - | 203,624,723.23 | - |
最新报告期：2026-09-23| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信建投 | 叶乐,张舒怡 | 1.55 | 1.75 | 1.95 | 2026-09-23 |
| 华创证券 | 刘一怡 | 1.55 | 1.75 | 1.96 | 2026-09-15 |
| 长江证券 | 于旭辉,魏杏梓 | 1.61 | 1.81 | 2.00 | 2026-09-14 |
| 东方财富证券 | 刘雪莹,赵树理 | 1.57 | 1.86 | 2.07 | 2026-09-11 |
| 招商证券 | 刘丽,王雪玉 | 1.54 | 1.76 | 1.92 | 2026-09-10 |